Autonomix Medical raises $2.5M via warrant exercise inducement, issues new Series B warrants

Autonomix Medical, Inc.

Existing warrant exercise price reduced to $1.723/share; holders exercise/prepay for 1,477,596 shares.
Gross proceeds ~$2.5M before fees; placement agent Ladenburg Thalmann receives 8% cash fee.
New Series B warrants for 1,477,596 shares at $1.723, 5.5-year term, immediately exercisable.
Company will file resale registration statement for new warrant shares by Aug 20, 2025.
Post-transaction common shares outstanding: 4,877,625.

item 1.01item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.